| Efficacy of six-dose regimen of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria, three years after its introduction into Ethiopia. | |
| | |
MedLine Citation:
|
PMID: 19585891 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We assessed the clinical and parasitological efficacy of six-dose regimen of artemether-lumefantrine (AL) (Coartem) for treating uncomplicated P. falciparum malaria three years after its introduction into Ethiopia. A total of 102 patients (mean age: 15.7 years; age range: 1-50 years) were enrolled in the study and followed-up for 28 days based on WHO protocol. Treatment with AL resulted in 100% adequate clinical and parasitological response (ACPR). No severe side-effect of the drug was observed. All patients had rapid clinical and parasitological responses. None of the subject was found to be positive for asexual or sexual stage of the parasite after day 3. A significant increase in the mean of haemoglobin level was observed on day 28 posttreatment (11.4 g/dL on day 0 vs 12.3 g/dL on day 28, p < 0.05). Thus, artemisinin-based combination therapies (ACTs) seem to mitigate not only the problem of drug resistance malaria but also the transmission of the disease. Nevertheless, monitoring ACT therapeutic efficacy is crucial in Ethiopia. |
| | |
Authors:
|
T Kefyalew; A Animut; T Tamene; D Jima; A Hailemariam; M Legesse |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Parasite (Paris, France) Volume: 16 ISSN: 1252-607X ISO Abbreviation: Parasite Publication Date: 2009 Jun |
Date Detail:
|
Created Date: 2009-07-09 Completed Date: 2009-10-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9437094 Medline TA: Parasite Country: France |
Other Details:
|
Languages: eng Pagination: 129-34 Citation Subset: IM |
Affiliation:
|
Aklilu Lemma Institute of Pathobiology, Addis Ababa University, P.O.B. 1176, Ethiopia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Antimalarials / administration & dosage, therapeutic use* Artemisinins / administration & dosage, therapeutic use* Child Child, Preschool Drug Combinations Ethanolamines / administration & dosage, therapeutic use* Ethiopia Female Fluorenes / administration & dosage, therapeutic use* Humans Infant Malaria, Falciparum / complications, drug therapy* Malaria, Vivax / complications, drug therapy Male Middle Aged Treatment Outcome Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Antimalarials; 0/Artemisinins; 0/Drug Combinations; 0/Ethanolamines; 0/Fluorenes; 0/artemether-lumefantrine combination |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of speed and duration of efficacy of spinosad tablets for treatment and control of Ctenoc...
Next Document: Establishment of a continuous culture system for Entamoeba muris and analysis of the small subunit r...